Announced Sat, 7 Feb · 23:57 IST

Centenial Surgical Suture Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 ,inter alia, to consider and approve 1. Standalone Un-Audited ....

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Centenial Surgical Suture Ltd has informed BSE that its Board of Directors will meet on Thursday, February 12, 2026. The key agenda is to approve the Standalone Un-Audited Financial Results for the quarter and nine months ended December 31, 2025. Any other business with the chair's permission may also be transacted. Additionally, the trading window for dealing in the company's securities is already closed from January 1, 2026 until 48 hours after the results are declared on the stock exchange, in line with insider trading regulations.

Likely market impact

This is a routine regulatory intimation and does not itself impact the stock price. Investors should watch for the Q3 FY26 results announcement on or after February 12, 2026, which may influence short-term price movement.